Collection of Follow-up Data From CP-690,550-treated Kidney Transplant Recipients
Status:
Completed
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
This is an observational study designed to collect follow-up clinical date on subjects who
were treated with tofacitinib in 2 completed Phase 2 studies who either discontinued
treatment prematurely or did not elect to enroll in long-term extension studies.